Great deep dive into a real problem that is hurting our ability to develop new drugs. A lot of this is closely related to regulatory capture where the incumbents are incentivized to use inefficient third parties and to ignore better ways of conducting clinical trials. I know a little about this because I worked at Abbott Labs briefly in their statistical clinical trials department.
Great deep dive into a real problem that is hurting our ability to develop new drugs. A lot of this is closely related to regulatory capture where the incumbents are incentivized to use inefficient third parties and to ignore better ways of conducting clinical trials. I know a little about this because I worked at Abbott Labs briefly in their statistical clinical trials department.
Would be great to hear more about your perspective into this and how transparency would help with specific details.
It's sometimes hard to explain to people the dynamics of the market, because how do you explain smth that's opaque?
You are doing genuinely valuable unlike crypto creatures.
I don’t think crypto is bad